HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension.

Abstract
The most abundant substance in the urinary free steroid fraction of patients with primary aldosteronism has been identified as 18-hydroxycortisol. 18-hydroxycortisol is very likely an adrenocortical secretory product rather than a peripheral metabolite, since it is abundantly synthesized by aldosteronoma tissue slices. The biogenesis of 18-hydroxycortisol takes place from cortisol rather than from 18-hydroxycorticosterone; that is, 17 alpha-precedes 18-hydroxylation. Cortisol 18-hydroxylation appears to be unrelated to the two other types of adrenocortical hydroxylation at this position. The pathway is present to a small extent in the normal human adrenal cortex and is only moderately stimulated by ACTH. Cortisol 18-hydroxylation is markedly accentuated in two circumstances: in the aldosteronoma cell where its presence may serve to distinguish tumor from bilateral hyperplasia and in ACTH-stimulatable hyperaldosteronism where it represents the first qualitative steroid biochemical abnormality to be demonstrated and as such may be useful in diagnosis and genetic studies. The possible contribution of 18-hydroxycortisol to the severity of the clinical manifestations of mineralocorticoid excess in these two types of aldosteronism remains to be explored.
AuthorsS Ulick, M D Chu
JournalClinical and experimental hypertension. Part A, Theory and practice (Clin Exp Hypertens A) Vol. 4 Issue 9-10 Pg. 1771-7 ( 1982) ISSN: 0730-0077 [Print] United States
PMID7139974 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Aldosterone
  • 18-hydroxycortisol
  • Hydrocortisone
Topics
  • Adenoma (metabolism)
  • Adrenal Cortex (metabolism)
  • Aldosterone (metabolism)
  • Humans
  • Hydrocortisone (analogs & derivatives, metabolism)
  • Hyperaldosteronism (physiopathology)
  • Hypertension (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: